System for prognosticating patient outcomes and methods of using the same
Abstract
Systems and Methods for prognosticating an outcome in a patient by integrating a hemodynamic parameter (Hdp) monitoring system and a Radio Frequency generator synchronized by a processing system is disclosed. The system is capable of identifying health condition-specific Hdp variation values changes in a patient upon the exposure of low-energy amplitude modulated electromagnetic field frequencies. The construction of a library of frequencies can be used to more efficiently and effectively predict or treat an outcome in a patient by auto-tuning a treatment regimen specifically to the patient.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 - 22 . (canceled)
23 . A system for prognosticating an outcome for a patient, the system comprising:
a monitoring system configured to detect a hemodynamic parameter exhibited by the patient; a generator configured to output low-energy radio frequency electromagnetic fields; and a processing system coupled to the monitoring system and the generator, the processing system configured to:
receive, via the monitoring system, a plurality of first values for the hemodynamic parameter during a nonexposure period in which the patient is not exposed to the low-energy radio frequency electromagnetic fields,
receive, via the monitoring system, a plurality of second values for the hemodynamic parameter during an exposure period in which the patient is exposed to the low-energy radio frequency electromagnetic fields, and
determine the outcome for the patient based on a comparison between the plurality of first values and the plurality of second values.
24 . The system of claim 23 , wherein the outcome is selected from the group consisting of quality of life, survival, and hospital admission.
25 . The system of claim 23 , wherein the low-energy radio frequency electromagnetic fields are configured to influence a cellular function of the patient.
26 . The system of claim 23 , wherein a frequency of the low-energy radio frequency electromagnetic fields is from about 0.01 Hz to about 150 kHz.
27 . The system of claim 23 , wherein a specific absorption rate of the low-energy radio frequency electromagnetic fields by the patient is less than about 1.6 mW/g.
28 . The system of claim 23 , wherein the low-energy radio frequency electromagnetic fields comprise amplitude-modulated carrier signals.
29 . A method for prognosticating an outcome for a patient using a monitoring system configured to detect a hemodynamic parameter exhibited by the patient and a generator configured to output low-energy radio frequency electromagnetic fields, the method comprising:
receiving, by a processing system, a plurality of first values for the hemodynamic parameter from the monitoring system during a nonexposure period in which the patient is not exposed to the low-energy radio frequency electromagnetic fields by the generator; receiving, by the processing system, a plurality of second values for the hemodynamic parameter from the monitoring system during an exposure period in which the patient is exposed to the low-energy radio frequency electromagnetic fields by the generator; and determining, by the processing system, the outcome for the patient based on a comparison between the plurality of first values and the plurality of second values.
30 . The method of claim 29 , wherein the outcome is selected from the group consisting of quality of life, survival, and hospital admission.
31 . The method of claim 29 , wherein the low-energy radio frequency electromagnetic fields are configured to influence a cellular function of the patient.
32 . The method of claim 29 , wherein a frequency of the low-energy radio frequency electromagnetic fields is from about 0.01 Hz to about 150 kHz.
33 . The method of claim 29 , wherein a specific absorption rate of the low-energy radio frequency electromagnetic fields by the patient is less than about 1.6 mW/g.
34 . The method of claim 29 , wherein the low-energy radio frequency electromagnetic fields comprise amplitude-modulated carrier signals.Join the waitlist — get patent alerts
Track US2023346289A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.